On Wednesday, Lupin shares were trading at its 52-week high of Rs 1,239.90, up by 1.42% from its previous closing of Rs 1,222.45 on the BSE. USFDA approval for Pitavastatin Lupin has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Pitavastatin Tablets, 1 mg, 2 …